Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia
Susanna C. Larsson, Stephen Burgess, Dipender Gill
Abstract
<b>Respiratory disease is a main feature of severe COVID-19, and the potential of IL-6 receptor blockade to increase risk of pneumonia warrants vigilance and caution in its application to treat COVID-19</b>https://bit.ly/34Y8Ner
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)PneumoniaBlockade2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Vigilance (psychology)ImmunologyReceptorDiseaseVirologyInternal medicineInfectious disease (medical specialty)OutbreakBiologyNeuroscienceCOVID-19 Clinical Research StudiesPARP inhibition in cancer therapyInflammasome and immune disorders